Cargando…
The Early Impact of the IDEA Collaboration Results: How the Results Changed Prescribing Practice
BACKGROUND: Traditionally, adjuvant treatment for colon cancer has been 6 months of combination chemotherapy. Six phase III trials tested the hypothesis that 3 months is noninferior in efficacy to 6 months and reduces long-term side effects for patients. The results were pooled in the International...
Autores principales: | Iveson, Timothy, Hanna, Catherine, Iveson, Poppy, Zhang, Sui, Levasseur, Alexandra, Meyerhardt, Jeffrey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8328095/ https://www.ncbi.nlm.nih.gov/pubmed/34350375 http://dx.doi.org/10.1093/jncics/pkab043 |
Ejemplares similares
-
The IDEA (International Duration Evaluation of Adjuvant Chemotherapy) Collaboration: Prospective Combined Analysis of Phase III Trials Investigating Duration of Adjuvant Therapy with the FOLFOX (FOLFOX4 or Modified FOLFOX6) or XELOX (3 versus 6 months) Regimen for Patients with Stage III Colon Cancer: Trial Design and Current Status
por: André, Thierry, et al.
Publicado: (2013) -
Early-life predictors of retirement decisions and post-retirement health
por: Iveson, Matthew H., et al.
Publicado: (2019) -
Childhood cognitive ability and the risk of self-harm and suicide in later life.
por: Iveson, Matthew
Publicado: (2022) -
Management of advanced colorectal cancer: state of the art
por: Saunders, M, et al.
Publicado: (2006) -
Systematic searching: practical ideas for improving results
por: Gore, Genevieve
Publicado: (2023)